Daysita M 50/500mg Tablet

Daysita M 50/500mg Tablet is a combination medication containing two active ingredients: Sitagliptin & Metformin. It is prescribed for the management of type 2 diabetes mellitus to help control blood sugar levels.

Components:

• Sitagliptin: Belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. It enhances the levels of incretin hormones, which stimulate the release of insulin and reduce the amount of glucose produced by the liver.
• Metformin: Falls under the category of biguanide antidiabetic agents. It decreases the production of glucose in the liver and improves the body’s response to insulin, enhancing the utilization of glucose by cells.

Uses:

Daysita M 50/500mg Tablet is indicated for the treatment of type 2 diabetes mellitus. The combination of Sitagliptin and Metformin provides dual mechanisms to control blood sugar levels, making it beneficial for individuals requiring additional glycemic control.

Side Effects:

Common side effects may include gastrointestinal symptoms, such as nausea, vomiting, and diarrhea. Low blood sugar (especially when combined with other antidiabetic medications) and upper respiratory tract infections may also occur. Report any unusual or severe side effects to your healthcare provider.

Precautions:

• Inform your healthcare provider about any pre-existing medical conditions, especially kidney problems or a history of lactic acidosis.
• Disclose all medications, including prescription and over-the-counter drugs, as well as any herbal supplements, to avoid potential interactions.
• Monitor for signs of lactic acidosis, particularly if there are episodes of vomiting or diarrhea.

When Not to Use:

Daysita M 50/500mg Tablet may not be suitable for use in the following situations:

• Known hypersensitivity or allergy to Sitagliptin, Metformin, or any components of the medication.
• Severe renal impairment or end-stage renal disease.
• History of lactic acidosis or conditions that may predispose to lactic acidosis.